Literature DB >> 1811277

The influence of divalent cations and doxycycline on iodoacetamide-inhibitable leukocyte adherence.

W L Gabler1, N Tsukuda.   

Abstract

Leukocyte adherence, an event critical to host defense, is reported to be dependent upon divalent cations. To test whether leukocyte binding is more influenced by the availability of Ca2+ or Mg2+, neutrophils and mononuclear leukocyte adherence to surfaces coated with differing proteins, in medium containing varying concentrations of Ca2+ and/or Mg2+ and induced with either FMLP or PMA were assessed. To account for nonspecific leukocyte-substrata interactions the OD's of iodoacetamide-inhibited adherent cell systems were subtracted from the OD values of adherent cells of noninhibited systems. Values presented were derived from OD's of iodoacetamide-inhibitable leukocyte binding. PMA was a much more potent inducer of leukocyte adherence than was FMLP, stimulating all available neutrophils and monocytes to adhere. In contrast, FMLP induced adherence by roughly 1/4 of the available neutrophils and few, if any, monocytes. Roughly the same binding pattern was noted whether surfaces were coated with albumin, fibrinogen, fibronectin, gelatin or serum. EDTA but not EGTA significantly suppressed leukocyte binding suggesting Mg2+ was more involved in binding than was Ca2+. Little leukocyte adherence to a substrata occurred in the absence of divalent cations, while enrichment of the medium with Mg2+ was more influential on cell binding than was enrichment with Ca2+. Interestingly, doxycycline, a member of the tetracycline family of drugs which has been reported to inhibit Mg(2+)-dependent neutrophil functions, had a slight inhibitory effect on neutrophil adherence at low drug concentrations, while it enhanced binding at higher doxycycline concentrations. In contrast, the tetracycline inhibited monocyte adherence in a dose-related manner.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1811277

Source DB:  PubMed          Journal:  Res Commun Chem Pathol Pharmacol        ISSN: 0034-5164


  9 in total

Review 1.  Immunomodulation by antibacterial agents. Is it clinically relevant?

Authors:  M T Labro
Journal:  Drugs       Date:  1993-03       Impact factor: 9.546

Review 2.  Tetracyclines: a pleitropic family of compounds with promising therapeutic properties. Review of the literature.

Authors:  Michael O Griffin; Eduardo Fricovsky; Guillermo Ceballos; Francisco Villarreal
Journal:  Am J Physiol Cell Physiol       Date:  2010-06-30       Impact factor: 4.249

Review 3.  Immunomodulating effects of antibiotics: literature review.

Authors:  B Van Vlem; R Vanholder; P De Paepe; D Vogelaers; S Ringoir
Journal:  Infection       Date:  1996 Jul-Aug       Impact factor: 3.553

4.  Doxycycline treatment reduces ischemic brain damage in transient middle cerebral artery occlusion in the rat.

Authors:  W M Clark; N Lessov; J D Lauten; K Hazel
Journal:  J Mol Neurosci       Date:  1997-10       Impact factor: 3.444

5.  Doxycycline suppression of ischemia-reperfusion-induced hepatic injury.

Authors:  J R Smith; W L Gabler
Journal:  Inflammation       Date:  1994-04       Impact factor: 4.092

Review 6.  Tetracycline compounds with non-antimicrobial organ protective properties: possible mechanisms of action.

Authors:  Michael O Griffin; Guillermo Ceballos; Francisco J Villarreal
Journal:  Pharmacol Res       Date:  2010-10-14       Impact factor: 7.658

7.  Inflammation aggravates disease severity in Marfan syndrome patients.

Authors:  Teodora Radonic; Piet de Witte; Maarten Groenink; Vivian de Waard; Rene Lutter; Marco van Eijk; Marnix Jansen; Janneke Timmermans; Marlies Kempers; Arthur J Scholte; Yvonne Hilhorst-Hofstee; Maarten P van den Berg; J Peter van Tintelen; Gerard Pals; Marieke J H Baars; Barbara J M Mulder; Aeilko H Zwinderman
Journal:  PLoS One       Date:  2012-03-30       Impact factor: 3.240

Review 8.  Tetracycline and viruses: a possible treatment for COVID-19?

Authors:  Jesús A Mosquera-Sulbaran; Hugo Hernández-Fonseca
Journal:  Arch Virol       Date:  2020-11-02       Impact factor: 2.574

Review 9.  Combined therapy with ivermectin and doxycycline can effectively alleviate the cytokine storm of COVID-19 infection amid vaccination drive: A narrative review.

Authors:  Satish Kumar Sharma; Pankaj Bhatt; Syed Mohammed Basheeruddin Asdaq; Mohammed Kanan Alshammari; Abeer Alanazi; Naif Saleh Alrasheedi; Bader Abdullah Alrashdi; Saad Saleh Alyami; Bshayer Hamdan Alhazmi; Perwaiz Alam; Prerna Sharma; Ritu Tomar; Mandeep K Arora; Mohd Imran
Journal:  J Infect Public Health       Date:  2022-03-30       Impact factor: 7.537

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.